SCHEMBL1758657

SCHEMBL1758657

CC(C(=O)O)c1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 9/20 0.54
AKR1C2 P52895 8/20 0.54
PTGS2 P35354 10/20 0.53
PTGS1 P23219 8/20 0.50
CYP2C9 P11712 4/20 0.50
LMNA P02545 3/20 0.50
CXCR1 P25024 2/20 0.50
CXCR2 P25025 2/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
TSHR P16473 2/20 0.50
ALB P02768 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX5 P09917 1/20 0.50
RARB P10826 1/20 0.50
ADRB3 P13945 1/20 0.50
NFKB1 P19838 1/20 0.50
HTR2A P28223 1/20 0.50
NR1I3 Q14994 1/20 0.50
CXCL8 P10145 1/20 0.50
BLM P54132 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7603230 0.86 ALDH1A1 (0.41) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL13723847 0.82 AKR1C3 (0.70) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL59197 0.81 PTGS2 (0.74) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL8441696 0.81 ALDH1A1 (0.55) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL166813 0.79 PTGS2 (0.53) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL9228365 0.79 PTGS2 (0.61) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL995303 0.79 PTGS1 (0.53) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL18151426 0.78 CA12 (0.44) PTGS2LMNATSHRALDH1A1HPGD
SCHEMBL343985 0.77 ALDH1A1 (0.50) PTGS2LMNAHTR2AALDH1A1HSD17B10
SCHEMBL8469242 0.76 APP (0.47) AKR1C3AKR1C2PTGS2LMNACXCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809822-B2 Triptolide derivatives and preparation method and use thereof HONG KONG BAPTIST UNIVERSITY (HK) 2017-11-07 US claimed
US-9809822-B2 Triptolide derivatives and preparation method and use thereof HONG KONG BAPTIST UNIVERSITY (HK) 2017-11-07 US disclosed
US-20160362691-A1 TRIPTOLIDE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF HONG KONG BAPTIST UNIVERSITY (HK) 2016-12-15 US disclosed
WO-2011058582-A1 HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF FUNGAL INFECTIONS ORCHID RESEARCH LABORATORIES LTD. (IN) 2011-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160362691-A1 TRIPTOLIDE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF TPD52L2, TRDMT1, MCTS1 AKR1C3 377/4885AKR1C2 501/4885PTGS2 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.